Reports for ACT CIPROFLOXACIN
Brand name
ACT CIPROFLOXACIN
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02247340 |
Ingredients
CIPROFLOXACIN |
Ingredient Strength
500 MG |
ATC Code
J01MA |
ATC Descriptor
QUINOLONE ANTIBACTERIALS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| ACT CIPROFLOXACIN | 100 | Resolved | 2021-02-05 | 2023-06-09 | 133460 |
| ACT CIPROFLOXACIN | 100 | Resolved | 2020-04-02 | 2020-05-21 | 110643 |
| ACT CIPROFLOXACIN | 100 | Resolved | 2019-09-12 | 2019-10-10 | 93644 |
| ACT CIPROFLOXACIN | 100 | Resolved | 2019-06-18 | 2019-07-15 | 86923 |
| ACT CIPROFLOXACIN | 100 | Resolved | 2018-12-04 | 2019-03-12 | 68599 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0